Cohort Study: Use of Phosphodiesterase 5 Inhibitors linked to increased risk of ocular adverse events.
8 Apr, 2022 | 11:04h | UTCRisk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US – JAMA Ophthalmology (free for a limited period)
News Release: U.S. insurance claims show strong link between ED medications and vision problems – University of British Columbia
Commentaries:
Phase 4 Studies on Phosphodiesterase 5 Inhibitors – JAMA Ophthalmology (free for a limited period)
Could Viagra, Cialis Raise Men’s Odds for Eye Trouble? – HealthDay